NCT03779815View on ClinicalTrials.gov

Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 20, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Multiple Myeloma
Interventions
DRUG

[18F]Florbetaben

"* Drug: \[18F\]Florbetaben~* \[18F\]Florbetaben PET/CT Imaging for detecting amyloidosis in multiple myeloma~* Other name: Neuraceq~* Amount: 300 MBq ± 20% bolus, 10mL intravenously"

Trial Locations (1)

Unknown

Ulsan University Hospital, Ulsan

All Listed Sponsors
lead

Ulsan University Hospital

OTHER

NCT03779815 - Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography | Biotech Hunter | Biotech Hunter